A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.
Prolamins in the endosperm of SEEDS from the Triticeae tribe which includes species of WHEAT; BARLEY; and RYE.
Simple protein, one of the prolamines, derived from the gluten of wheat, rye, etc. May be separated into 4 discrete electrophoretic fractions. It is the toxic factor associated with CELIAC DISEASE.
A diet which is devoid of GLUTENS from WHEAT; BARLEY; RYE; and other wheat-related varieties. The diet is designed to reduce exposure to those proteins in gluten that trigger INFLAMMATION of the small intestinal mucosa in patients with CELIAC DISEASE.
Transglutaminases catalyze cross-linking of proteins at a GLUTAMINE in one chain with LYSINE in another chain. They include keratinocyte transglutaminase (TGM1 or TGK), tissue transglutaminase (TGM2 or TGC), plasma transglutaminase involved with coagulation (FACTOR XIII and FACTOR XIIIa), hair follicle transglutaminase, and prostate transglutaminase. Although structures differ, they share an active site (YGQCW) and strict CALCIUM dependence.
A scleroprotein fibril consisting mostly of type III collagen. Reticulin fibrils are extremely thin, with a diameter of between 0.5 and 2 um. They are involved in maintaining the structural integrity in a variety of organs.
Rare, chronic, papulo-vesicular disease characterized by an intensely pruritic eruption consisting of various combinations of symmetrical, erythematous, papular, vesicular, or bullous lesions. The disease is strongly associated with the presence of HLA-B8 and HLA-DR3 antigens. A variety of different autoantibodies has been detected in small numbers in patients with dermatitis herpetiformis.
The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers.
Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions.
The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum.
Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI.
A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
A group of seed storage proteins restricted to the POACEAE family. They are rich in GLUTAMINE and PROLINE.
A plant species of the family POACEAE that is widely cultivated for its edible seeds.
A subunit of the interleukin-18 receptor that plays a role in receptor signaling by association of its cytoplasmic domain with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88.
By adjusting the quantity and quality of food intake to improve health status of an individual. This term does not include the methods of food intake (NUTRITIONAL SUPPORT).
An HLA-DR antigen which is associated with HLA-DRB1 CHAINS encoded by DRB1*03 alleles.
A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN A.
A HLA-DR antigen that is associated with HLA-DRB1 CHAINS encoded by DRB1*07 alleles.
Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.
A diet that contains limited amounts of protein. It is prescribed in some cases to slow the progression of renal failure. (From Segen, Dictionary of Modern Medicine, 1992)
Allergic reaction to wheat that is triggered by the immune system.
Diagnostic procedures involving immunoglobulin reactions.
A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p887)
Endoscopic examination, therapy or surgery of the luminal surface of the duodenum.
Endoscopic examination, therapy or surgery of the gastrointestinal tract.
Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
A condition that is characterized by chronic fatty DIARRHEA, a result of abnormal DIGESTION and/or INTESTINAL ABSORPTION of FATS.
Inflammation of the DUODENUM section of the small intestine (INTESTINE, SMALL). Erosive duodenitis may cause bleeding in the UPPER GI TRACT and PEPTIC ULCER.
Non-invasive, endoscopic imaging by use of VIDEO CAPSULE ENDOSCOPES to perform examination of the gastrointestinal tract, especially the small bowel.
Tumors or cancer in the JEJUNUM region of the small intestine (INTESTINE, SMALL).
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Pathological development in the JEJUNUM region of the SMALL INTESTINE.
Tumors or cancer of the INTESTINES.
A primary peripheral T-cell lymphoma in the gastrointestinal tract, most often in the jejunum, associated with a history of CELIAC DISEASE or other gastrointestinal diseases.
Inflammation of any segment of the SMALL INTESTINE.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
Absorptive cells in the lining of the INTESTINAL MUCOSA. They are differentiated EPITHELIAL CELLS with apical MICROVILLI facing the intestinal lumen. Enterocytes are more abundant in the SMALL INTESTINE than in the LARGE INTESTINE. Their microvilli greatly increase the luminal surface area of the cell by 14- to 40 fold.
Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
A condition characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. This syndrome was first described in 1980 by Read and associates. Subtypes include COLLAGENOUS COLITIS and LYMPHOCYTIC COLITIS. Both have similar clinical symptoms and are distinguishable only by histology.
Endoscopic examination, therapy or surgery of the digestive tract.

Coeliac disease and dermatitis herpetiformis: further studies of their relationship. (1/1975)

Using diagnostic criteria which are currently accepted as most reliable we have found that 19% (9/47) of patients with dermatitis herpetiformis (DH) have no evidence of coeliac disease. The incidence of HL-A8 in the DH patients was 78%, which is considerably greater than that in healthy controls and no different from that reported in coeliac disease. Furthermore, the incidence of HL-A8 was just as much increased in those DH patients without evidence of coeliac disease suggesting that HL-A8 is associated with DH per se--that is, regardless of its association with coeliac disease.  (+info)

Coeliac disease detected by screening is not silent--simply unrecognized. (2/1975)

Coeliac disease (CD) is associated with a wide spectrum of clinical presentation and may be overlooked as a diagnosis. There is some evidence that untreated CD is associated with a doubling of mortality, largely due to an increase in the incidence of malignancy and small intestinal lymphoma, which is decreased by a strict gluten-free diet. We studied the clinical features of screening-detected coeliacs compared to age- and sex-matched controls as a 3-year follow-up to a population screening survey, and followed-up subjects who had had CD-associated serology 11 years previously to determine whether they have CD or an increased mortality rate compared to the general population. Samples of the general population (MONICA 1991 and 1983) were screened for CD-associated serology and followed-up after 3 and 11 years, respectively, and assessed by a clinical questionnaire, screening blood tests and jejunal biopsy. Mortality rates for 'all deaths' and 'cancer deaths' were compared in subjects with positive serology in 1983 with reference to the general population. Thirteen coeliacs were diagnosed by villous atrophy following screening, compared to two patients with clinically detected CD, giving a prevalence of 1:122. Clinical features or laboratory parameters were not indicative of CD compared to controls. Subjects with positive serology followed up after 11 years did not have an excess mortality for either cancer deaths or all causes of death. Screening-detected CD is rarely silent and may be associated with significant symptoms and morbidity. In this limited study with small numbers, there does not appear to be an increased mortality from screening-detected CD, although the follow-up may be too short to detect any difference.  (+info)

The widening spectrum of celiac disease. (3/1975)

Celiac disease is a permanent intolerance to ingested gluten that results in immunologically mediated inflammatory damage to the small-intestinal mucosa. Celiac disease is associated with both human leukocyte antigen (HLA) and non-HLA genes and with other immune disorders, notably juvenile diabetes and thyroid disease. The classic sprue syndrome of steatorrhea and malnutrition coupled with multiple deficiency states may be less common than more subtle and often monosymptomatic presentations of the disease. Diverse problems such as dental anomalies, short stature, osteopenic bone disease, lactose intolerance, infertility, and nonspecific abdominal pain among many others may be the only manifestations of celiac disease. The rate at which celiac disease is diagnosed depends on the level of suspicion for the disease. Although diagnosis relies on intestinal biopsy findings, serologic tests are useful as screening tools and as an adjunct to diagnosis. The treatment of celiac disease is lifelong avoidance of dietary gluten. Gluten-free diets are now readily achievable with appropriate professional instruction and community support. Both benign and malignant complications of celiac disease occur but these can often be avoided by early diagnosis and compliance with a gluten-free diet.  (+info)

Urinary outputs of oxalate, calcium, and magnesium in children with intestinal disorders. Potential cause of renal calculi. (4/1975)

24-hour urinary outputs of oxalate, calcium, and magnesium have been determined in a total of 62 children aged 3 months to 17 years who fell into the following groups: (i) 16 normal controls, (ii) 3 with primary hyperoxaluria, (iii) 9 with small and/or large intestinal resections, (iv) 9 with untreated coeliac disease, (v) 5 with pancreatic dysfunction, and (vi) a miscellaneous group of 20 children with a variety of intestinal disorders. Taken as a whole, 58% of patients with intestinal disorders had hyperoxaluria, and of these 7% had urinary outputs of oxalate which fell within the range seen in primary hyperoxaluria. The proportion of children with hyperoxaluria in the different diagnostic groups was as follows: intestinal resections (78%), coeliac disease (67%), pancreatic dysfunction (80%), and miscellaneous (45%). 35% of the patients with hyperoxaluria had hypercalciuria, whereas magnesium excretion was normal in all subjects studied. In 2 patients treatment of the underlying condition was accompanied by a return of oxalate excretion to normal. These results indicate that hyperoxaluria and hypercalciuria are common in children with a variety of intestinal disorders, and that such children may be at risk of developing renal calculi without early diagnosis and treatment.  (+info)

Management of coeliac disease: a changing diagnostic approach but what value in follow up? (5/1975)

OBJECTIVE: To assess the management of patients with coeliac disease in relation to a change in diagnostic method from jejunal suction biopsy to endoscopic biopsy. DESIGN: 16 item questionnaire survey of consultant members of the British Society of Gastroenterology. SUBJECTS: 359 consultant physician and gastroenterologist members of the society. MAIN MEASURES: Type of routine biopsy; repeat biopsy after gluten withdrawal; gluten rechallenge; follow up measurements; screening for malignancy; and methods of follow up, including special clinics. RESULTS: 270(70%) members replied; 216(80%) diagnosed coeliac disease routinely by endoscopic duodenal biopsy, 30(11%) by jejunal capsule biopsy, and the remainder by either method. Only 156(58%) repeated the biopsy after gluten withdrawal, though more did so for duodenal than jejunal biopsies (134/216, 62% v 13/30, 43%; p < 0.02). Follow up biopsies featured more duodenal than jejunal biopsies (133/156, 82% v 23/156, 15%; p < 0.02). Regular follow up included assessments of weight (259, 96%) and full blood count (238, 88%) but limited assessment of serum B-12 and folate (120, 44%) and calcium (105, 39%) concentrations. Routine screening for malignancy is not performed, and there are few specialist clinics. 171(63%) respondents thought that patients should be followed up by a hospital specialist and 58(21%) by family doctors. CONCLUSIONS: The practice of diagnosing coeliac disease varies appreciably from that in many standard texts. Many patients could be effectively cared for by their family doctor. IMPLICATIONS: The British Society of Gastroenterology should support such management by family doctors by providing clear guidelines for them.  (+info)

Patchiness and duodenal-jejunal variation of the mucosal abnormality in coeliac disease and dermatitis herpetiformis. (6/1975)

The incidence and degree of patchiness of mucosal abnormality in both coeliac disease (CD) and dermatitis herpetiformis (DH) is documented. As judged by both stereomicroscopy and subjective histology, patchiness occurred frequently in both CDand DH patients. In most cases the difference of abnormality was of only one grade, but in approximately 25% as assessed by stereomicroscopy and 10% as assessed by histology the difference was of two or more grades. In control subjects with normal small bowel mucosa the variation of the mucosal appearance between the duodenum and proximal jejunum was studied. Contrary to popular belief, no significant difference of villous and crypt measurements or of apparent villous "bridging" and "branching" between these two sites was found, if only well-orientated sections were studied. The stereomicroscopic appearances were also similar at these two sites, although villi tended to be broader in the duodenal biopsies. The duodenal-jejunal variation was also studied in CD and DH patients and although by both stereomicroscopy and subjective histology the appearances were similar in most patients, in approximately 33% the duodenal abnormality was the most severe and, surprisingly, the jejunal abnormality was more severe in approximately 15%. It is concluded that multiple, precisely located biopsies of both the duodenum and proximal jejunum are invaluable in the investigation of small bowel disease and in assessing response to treatment.  (+info)

CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. (7/1975)

BACKGROUND: Susceptibility to coeliac disease is strongly associated with particular HLA class II alleles. However, non-HLA genetic factors are likely to be required for the development of the disease. Among candidate genes is the CTLA-4 (cytotoxic T lymphocyte associated) gene located on chromosome 2q33 in humans, which encodes a cell surface molecule providing a negative signal for T cell activation. AIMS: To investigate CTLA-4 exon 1 polymorphism (position 49 A/G) in patients with coeliac disease. PATIENTS: 101 patients with coeliac disease and 130 healthy controls. METHODS: Allele specific hybridisation and restriction enzyme digestion of polymerase chain reaction amplified genomic DNA. RESULTS: The A allele of the CTLA-4 position 49 polymorphism was found on 82.2% of chromosomes in patients with coeliac disease compared with 65.8% in controls (p < 0.0001), mostly in the homozygous form (68.3% in patients versus 47.7% in controls; odds ratio (OR) 2.36, 95% confidence interval (CI) 1.37 to 4.06, p = 0.002). Four patients only had the G/G genotype compared with 21 controls (OR 0.21, CI 10.07 to 0.64, p = 0.002). These differences were maintained when subjects were stratified according to the HLA class II phenotype, in particular when patients and controls were matched for the presence of the predisposing HLA DQB1*02 (DQ2) allele or HLA-DQA1*0501/DQB1*02 heterodimer. CONCLUSION: The CTLA-4 gene polymorphism is a non-HLA determinant that predisposes to coeliac disease. Whether it directly contributes to disease susceptibility or represents a marker for a locus in linkage disequilibrium with CTLA-4 needs further investigation.  (+info)

Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. (8/1975)

BACKGROUND: Several case reports, but only a few studies, have examined the coexistence of coeliac disease and primary biliary cirrhosis. AIM: To estimate the risk of primary biliary cirrhosis in two national cohorts of patients with coeliac disease in Denmark and Sweden. METHODS: Through record linkage all Danish patients hospitalised with coeliac disease were followed for possible occurrence of primary biliary cirrhosis from 1 January 1977 until 31 December 1992. All patients hospitalised with coeliac disease in Sweden from 1987 to 1996 were also followed in a separate analysis. RESULTS: A total of 896 patients with coeliac disease were identified in Denmark with a median follow up period of 9.1 years for a total of 8040 person-years at risk. Two cases of primary biliary cirrhosis were observed where 0.07 were expected, giving a standardised incidence ratio of 27.6 (95% confidence interval 2.9 to 133.5). A total of 7735 patients with coeliac disease were identified in Sweden with a median follow up period of 5.1 years for a total of 39 284 person-years at risk. Twenty two people with primary biliary cirrhosis were identified compared with 0.88 expected, giving a standardised incidence ratio of 25.1 (95% confidence interval 15.7 to 37.9). CONCLUSION: Patients with coeliac disease are at increased risk of having primary biliary cirrhosis.  (+info)

Celiac disease is a genetic autoimmune disorder in which the consumption of gluten, a protein found in wheat, barley, and rye, leads to damage in the small intestine. In people with celiac disease, their immune system reacts to gluten by attacking the lining of the small intestine, leading to inflammation and destruction of the villi - finger-like projections that help absorb nutrients from food.

This damage can result in various symptoms such as diarrhea, bloating, fatigue, anemia, and malnutrition. Over time, if left untreated, celiac disease can lead to serious health complications, including osteoporosis, infertility, neurological disorders, and even certain types of cancer.

The only treatment for celiac disease is a strict gluten-free diet, which involves avoiding all foods, beverages, and products that contain gluten. With proper management, individuals with celiac disease can lead healthy lives and prevent further intestinal damage and related health complications.

"Gluten" is not strictly defined as a medical term, but it refers to a group of proteins found in certain grains, including wheat, barley, and rye. Gluten gives these grains their elasticity and helps them maintain their shape, making it possible to bake breads and other baked goods.

From a medical perspective, gluten is significant because some people have adverse reactions to it. The two main conditions related to gluten are celiac disease and non-celiac gluten sensitivity. In both cases, consuming gluten can lead to various symptoms such as gastrointestinal distress, fatigue, and skin rashes.

Celiac disease is an autoimmune disorder where the ingestion of gluten causes damage to the small intestine lining, impairing nutrient absorption. On the other hand, non-celiac gluten sensitivity does not involve an immune response or intestinal damage but can still cause uncomfortable symptoms in some individuals.

It is essential to understand that a gluten-free diet should be medically recommended and supervised by healthcare professionals for those diagnosed with celiac disease or non-celiac gluten sensitivity, as it may lead to nutritional deficiencies if not properly managed.

Gliadin is a protein fraction found in gluten, a complex protein that's present in certain grains such as wheat, barley, and rye. It is particularly known for its role in celiac disease, a disorder where the ingestion of gluten leads to an immune response that damages the lining of the small intestine.

Gliadin, along with another protein fraction called glutenin, makes up gluten. Gliadin is responsible for the elastic properties of dough. When water is added to flour and mixed, these proteins form a sticky network that gives dough its characteristic texture and allows it to rise and maintain its shape during baking.

In individuals with celiac disease, the immune system recognizes gliadin as a foreign invader and mounts an immune response against it. This response leads to inflammation and damage in the small intestine, preventing the absorption of nutrients from food. Over time, this can lead to various health complications if not properly managed through a gluten-free diet.

A gluten-free diet is a diet that excludes the consumption of gluten, a protein found in wheat, barley, and rye. This type of diet is often recommended for individuals with celiac disease, non-celiac gluten sensitivity, or wheat allergies. Adhering to a strict gluten-free diet can help manage symptoms, heal intestinal damage, and prevent further complications associated with these conditions.

The medical definition of 'Diet, Gluten-Free' includes:

1. Celiac Disease: An autoimmune disorder where the ingestion of gluten leads to damage in the small intestine. Following a gluten-free diet is crucial for individuals with celiac disease to prevent symptoms and associated health complications.
2. Non-Celiac Gluten Sensitivity (NCGS): A condition where individuals experience adverse reactions to gluten, but do not test positive for celiac disease or wheat allergy. A gluten-free diet can help alleviate symptoms in those with NCGS.
3. Wheat Allergy: An allergic reaction to proteins found in wheat, which may include gluten. Excluding gluten from the diet can help manage symptoms in individuals with wheat allergy.
4. Dermatitis Herpetiformis (DH): A skin manifestation of celiac disease characterized by an itchy, blistering rash. A gluten-free diet is often recommended to control DH symptoms and prevent intestinal damage.
5. Gluten Ataxia: A neurological disorder associated with celiac disease where gluten ingestion can cause issues with balance, coordination, and speech. A gluten-free diet may help improve these symptoms in individuals with gluten ataxia.

It is essential to consult a healthcare professional or a registered dietitian for guidance on following a gluten-free diet to ensure proper nutrition and to avoid cross-contamination from gluten sources.

Transglutaminases are a family of enzymes that catalyze the post-translational modification of proteins by forming isopeptide bonds between the carboxamide group of peptide-bound glutamine residues and the ε-amino group of lysine residues. This process is known as transamidation or cross-linking. Transglutaminases play important roles in various biological processes, including cell signaling, differentiation, apoptosis, and tissue repair. There are several types of transglutaminases, such as tissue transglutaminase (TG2), factor XIII, and blood coagulation factor XIIIA. Abnormal activity or expression of these enzymes has been implicated in various diseases, such as celiac disease, neurodegenerative disorders, and cancer.

Reticulin is a type of protein fiber that forms part of the extracellular matrix in various connective tissues in the body. It is composed of collagenous and non-collagenous proteins, and it has a reticular or network-like structure when viewed under a microscope. In histology (the study of the microscopic structure of tissues), reticulin fibers are often stained to help identify certain types of cells or structures.

In particular, reticulin fibers are often found in close association with certain types of cells, such as hematopoietic stem cells and neurons. They provide structural support and help regulate the function of these cells. In addition, reticulin fibers play a role in the immune response, wound healing, and tissue repair.

Abnormal accumulations of reticulin fibers can be seen in various disease states, such as fibrosis (excessive scarring) and certain types of cancer. For example, increased reticulin fibers are often found in the liver in patients with cirrhosis, a condition characterized by extensive scarring and damage to the liver. Similarly, abnormal reticulin fiber deposition is seen in some forms of lymphoma, a type of cancer that affects the lymphatic system.

Dermatitis herpetiformis (DH) is a chronic, autoimmune blistering skin disorder that is characterized by the presence of symmetrical, pruritic (itchy), papulo-vesicular (papules and small fluid-filled blisters) eruptions on the extensor surfaces of the body, such as the elbows, knees, buttocks, and shoulders. It is often associated with gluten sensitivity or celiac disease, a condition that causes an abnormal immune response to gluten, a protein found in wheat, barley, and rye.

The exact cause of DH is not fully understood, but it is believed to result from the interaction between genetic, environmental, and immunological factors. The disorder is characterized by the presence of IgA antibodies in the skin, which trigger an immune response that leads to the formation of the characteristic rash.

DH is typically treated with a gluten-free diet, which can help to control the symptoms and prevent complications such as malabsorption and nutritional deficiencies. Medications such as dapsone may also be used to control the itching and blistering associated with the disorder. In some cases, topical corticosteroids or other anti-inflammatory medications may be prescribed to help manage symptoms.

It is important to note that DH is a chronic condition that requires ongoing management and monitoring. People with DH should work closely with their healthcare provider to develop an appropriate treatment plan and monitor their progress over time.

The duodenum is the first part of the small intestine, immediately following the stomach. It is a C-shaped structure that is about 10-12 inches long and is responsible for continuing the digestion process that begins in the stomach. The duodenum receives partially digested food from the stomach through the pyloric valve and mixes it with digestive enzymes and bile produced by the pancreas and liver, respectively. These enzymes help break down proteins, fats, and carbohydrates into smaller molecules, allowing for efficient absorption in the remaining sections of the small intestine.

Immunoglobulin A (IgA) is a type of antibody that plays a crucial role in the immune function of the human body. It is primarily found in external secretions, such as saliva, tears, breast milk, and sweat, as well as in mucous membranes lining the respiratory and gastrointestinal tracts. IgA exists in two forms: a monomeric form found in serum and a polymeric form found in secretions.

The primary function of IgA is to provide immune protection at mucosal surfaces, which are exposed to various environmental antigens, such as bacteria, viruses, parasites, and allergens. By doing so, it helps prevent the entry and colonization of pathogens into the body, reducing the risk of infections and inflammation.

IgA functions by binding to antigens present on the surface of pathogens or allergens, forming immune complexes that can neutralize their activity. These complexes are then transported across the epithelial cells lining mucosal surfaces and released into the lumen, where they prevent the adherence and invasion of pathogens.

In summary, Immunoglobulin A (IgA) is a vital antibody that provides immune defense at mucosal surfaces by neutralizing and preventing the entry of harmful antigens into the body.

The jejunum is the middle section of the small intestine, located between the duodenum and the ileum. It is responsible for the majority of nutrient absorption that occurs in the small intestine, particularly carbohydrates, proteins, and some fats. The jejunum is characterized by its smooth muscle structure, which allows it to contract and mix food with digestive enzymes and absorb nutrients through its extensive network of finger-like projections called villi.

The jejunum is also lined with microvilli, which further increase the surface area available for absorption. Additionally, the jejunum contains numerous lymphatic vessels called lacteals, which help to absorb fats and fat-soluble vitamins into the bloodstream. Overall, the jejunum plays a critical role in the digestion and absorption of nutrients from food.

The intestinal mucosa is the innermost layer of the intestines, which comes into direct contact with digested food and microbes. It is a specialized epithelial tissue that plays crucial roles in nutrient absorption, barrier function, and immune defense. The intestinal mucosa is composed of several cell types, including absorptive enterocytes, mucus-secreting goblet cells, hormone-producing enteroendocrine cells, and immune cells such as lymphocytes and macrophages.

The surface of the intestinal mucosa is covered by a single layer of epithelial cells, which are joined together by tight junctions to form a protective barrier against harmful substances and microorganisms. This barrier also allows for the selective absorption of nutrients into the bloodstream. The intestinal mucosa also contains numerous lymphoid follicles, known as Peyer's patches, which are involved in immune surveillance and defense against pathogens.

In addition to its role in absorption and immunity, the intestinal mucosa is also capable of producing hormones that regulate digestion and metabolism. Dysfunction of the intestinal mucosa can lead to various gastrointestinal disorders, such as inflammatory bowel disease, celiac disease, and food allergies.

HLA-DQ antigens are a type of human leukocyte antigen (HLA) that are found on the surface of cells in our body. They are a part of the major histocompatibility complex (MHC) class II molecules, which play a crucial role in the immune system by presenting pieces of proteins from outside the cell to CD4+ T cells, also known as helper T cells. This presentation process is essential for initiating an appropriate immune response against potentially harmful pathogens such as bacteria and viruses.

HLA-DQ antigens are encoded by genes located on chromosome 6p21.3 in the HLA region. Each individual inherits a pair of HLA-DQ genes, one from each parent, which can result in various combinations of HLA-DQ alleles. These genetic variations contribute to the diversity of immune responses among different individuals.

HLA-DQ antigens consist of two noncovalently associated polypeptide chains: an alpha (DQA) chain and a beta (DQB) chain. There are several isotypes of HLA-DQ antigens, including DQ1, DQ2, DQ3, DQ4, DQ5, DQ6, DQ7, DQ8, and DQ9, which are determined by the specific combination of DQA and DQB alleles.

Certain HLA-DQ genotypes have been associated with an increased risk of developing certain autoimmune diseases, such as celiac disease (DQ2 and DQ8), type 1 diabetes (DQ2, DQ8), and rheumatoid arthritis (DQ4). Understanding the role of HLA-DQ antigens in these conditions can provide valuable insights into disease pathogenesis and potential therapeutic targets.

A biopsy is a medical procedure in which a small sample of tissue is taken from the body to be examined under a microscope for the presence of disease. This can help doctors diagnose and monitor various medical conditions, such as cancer, infections, or autoimmune disorders. The type of biopsy performed will depend on the location and nature of the suspected condition. Some common types of biopsies include:

1. Incisional biopsy: In this procedure, a surgeon removes a piece of tissue from an abnormal area using a scalpel or other surgical instrument. This type of biopsy is often used when the lesion is too large to be removed entirely during the initial biopsy.

2. Excisional biopsy: An excisional biopsy involves removing the entire abnormal area, along with a margin of healthy tissue surrounding it. This technique is typically employed for smaller lesions or when cancer is suspected.

3. Needle biopsy: A needle biopsy uses a thin, hollow needle to extract cells or fluid from the body. There are two main types of needle biopsies: fine-needle aspiration (FNA) and core needle biopsy. FNA extracts loose cells, while a core needle biopsy removes a small piece of tissue.

4. Punch biopsy: In a punch biopsy, a round, sharp tool is used to remove a small cylindrical sample of skin tissue. This type of biopsy is often used for evaluating rashes or other skin abnormalities.

5. Shave biopsy: During a shave biopsy, a thin slice of tissue is removed from the surface of the skin using a sharp razor-like instrument. This technique is typically used for superficial lesions or growths on the skin.

After the biopsy sample has been collected, it is sent to a laboratory where a pathologist will examine the tissue under a microscope and provide a diagnosis based on their findings. The results of the biopsy can help guide further treatment decisions and determine the best course of action for managing the patient's condition.

The small intestine is the portion of the gastrointestinal tract that extends from the pylorus of the stomach to the beginning of the large intestine (cecum). It plays a crucial role in the digestion and absorption of nutrients from food. The small intestine is divided into three parts: the duodenum, jejunum, and ileum.

1. Duodenum: This is the shortest and widest part of the small intestine, approximately 10 inches long. It receives chyme (partially digested food) from the stomach and begins the process of further digestion with the help of various enzymes and bile from the liver and pancreas.
2. Jejunum: The jejunum is the middle section, which measures about 8 feet in length. It has a large surface area due to the presence of circular folds (plicae circulares), finger-like projections called villi, and microvilli on the surface of the absorptive cells (enterocytes). These structures increase the intestinal surface area for efficient absorption of nutrients, electrolytes, and water.
3. Ileum: The ileum is the longest and final section of the small intestine, spanning about 12 feet. It continues the absorption process, mainly of vitamin B12, bile salts, and any remaining nutrients. At the end of the ileum, there is a valve called the ileocecal valve that prevents backflow of contents from the large intestine into the small intestine.

The primary function of the small intestine is to absorb the majority of nutrients, electrolytes, and water from ingested food. The mucosal lining of the small intestine contains numerous goblet cells that secrete mucus, which protects the epithelial surface and facilitates the movement of chyme through peristalsis. Additionally, the small intestine hosts a diverse community of microbiota, which contributes to various physiological functions, including digestion, immunity, and protection against pathogens.

Autoantibodies are defined as antibodies that are produced by the immune system and target the body's own cells, tissues, or organs. These antibodies mistakenly identify certain proteins or molecules in the body as foreign invaders and attack them, leading to an autoimmune response. Autoantibodies can be found in various autoimmune diseases such as rheumatoid arthritis, lupus, and thyroiditis. The presence of autoantibodies can also be used as a diagnostic marker for certain conditions.

Prolamins are a type of protein found in various grains, such as wheat, rye, barley, and oats. They are rich in the amino acid proline and are soluble in alcohol but not water. Prolamins make up about 30-50% of the total protein content in these grains.

In wheat, the main prolamin is gliadin, which is responsible for triggering celiac disease, an autoimmune disorder that affects the small intestine. When people with celiac disease consume gluten (a protein found in wheat, rye, and barley), their immune system reacts to the gliadin component of gluten, causing damage to the lining of the small intestine. This can lead to various symptoms such as diarrhea, bloating, fatigue, and malnutrition.

Therefore, prolamins are important proteins to consider in the context of food intolerances and allergies, particularly for those with celiac disease or non-celiac gluten sensitivity.

'Avena sativa' is the scientific name for a type of grass species known as common oat or cultivated oat. It is widely grown as a crop for its seed, which is used as a food source for both humans and animals. Oats are rich in fiber, vitamins, minerals, and antioxidants, making them a popular choice for breakfast cereals, baked goods, and animal feeds. In addition to their nutritional value, oats have also been used in traditional medicine for various purposes, such as treating skin irritation and promoting hair growth.

The Interleukin-18 Receptor beta Subunit, also known as IL18Rβ or IL-1R5, is a protein that forms part of the interleukin-18 receptor complex. This receptor complex plays a crucial role in the immune system by mediating the inflammatory response. Interleukin-18 (IL-18) binds to the IL-18Rβ subunit, which then associates with the Interleukin-1 Receptor Accessory Protein (IL-1RAcP) to form a functional receptor complex. The activation of this receptor complex triggers intracellular signaling pathways that lead to the production of proinflammatory cytokines and chemokines, which in turn recruit immune cells to sites of infection or injury. Mutations in the IL18Rβ gene have been associated with various autoimmune and inflammatory diseases, highlighting its importance in maintaining immune homeostasis.

Diet therapy is a medical treatment that involves using specific dietary modifications to manage or treat various medical conditions. This can include changing the types and amounts of food consumed, as well as adjusting the timing and frequency of meals. The goal of diet therapy is to provide the body with the necessary nutrients to support healing and maintain health while also addressing any specific dietary needs or restrictions related to a particular medical condition.

Diet therapy may be used to treat a wide range of conditions, including diabetes, heart disease, high blood pressure, obesity, food allergies and intolerances, gastrointestinal disorders, and kidney disease. For example, a person with diabetes may be placed on a diet that restricts sugar and simple carbohydrates to help manage their blood sugar levels, while a person with heart disease may be advised to follow a low-fat, high-fiber diet to reduce their risk of heart attack and stroke.

Diet therapy is often used in conjunction with other medical treatments, such as medication and surgery, and should be prescribed and monitored by a healthcare professional, such as a registered dietitian or a doctor who specializes in nutrition. It is important for individuals to follow their specific dietary recommendations closely in order to achieve the best possible outcomes.

HLA-DR3 antigen is a type of human leukocyte antigen (HLA) class II histocompatibility antigen. HLAs are proteins found on the surface of cells that help the immune system distinguish between the body's own cells and foreign substances. The HLA-DR3 antigen is encoded by the DRB1*03:01 gene and is commonly found in individuals with certain autoimmune diseases, such as rheumatoid arthritis, type 1 diabetes, and celiac disease.

The HLA-DR3 antigen plays a role in presenting pieces of proteins (peptides) to CD4+ T cells, which are a type of white blood cell that helps coordinate the immune response. The presentation of specific peptides by the HLA-DR3 antigen can lead to an abnormal immune response in some individuals, resulting in the development of autoimmune diseases.

It's important to note that having the HLA-DR3 antigen does not guarantee that a person will develop an autoimmune disease, as other genetic and environmental factors also play a role.

IgA deficiency is a condition characterized by significantly reduced levels or absence of secretory immunoglobulin A (IgA), an important antibody that plays a crucial role in the immune function of mucous membranes lining the respiratory and gastrointestinal tracts. IgA helps to prevent the attachment and multiplication of pathogens, such as bacteria and viruses, on these surfaces.

In individuals with IgA deficiency, the lack of adequate IgA levels makes them more susceptible to recurrent infections, allergies, and autoimmune disorders. The condition can be asymptomatic or may present with various symptoms, such as respiratory tract infections, gastrointestinal issues, and chronic sinusitis. IgA deficiency is typically diagnosed through blood tests that measure the immunoglobulin levels. While there is no cure for IgA deficiency, treatment focuses on managing symptoms and preventing infections through medications, immunizations, and lifestyle modifications.

HLA-DR7 antigen is a human leukocyte antigen (HLA) serotype that is part of the major histocompatibility complex (MHC) class II, which plays a crucial role in the immune system. The HLA-DR7 antigen is encoded by the DRB1*07 gene and is expressed on the surface of antigen-presenting cells such as B lymphocytes, monocytes, and dendritic cells.

The HLA-DR7 antigen presents peptide fragments to CD4+ T helper cells, which then activate other immune cells like B cells and cytotoxic T cells to mount an immune response against pathogens or infected cells. The HLA-DR7 serotype is relatively common in many populations, with varying frequencies depending on the ethnic background.

It's important to note that certain HLA types, including HLA-DR7, have been associated with increased susceptibility or resistance to various diseases, such as autoimmune disorders and infectious diseases. However, the relationship between HLA types and disease is complex and not fully understood, as it involves multiple genetic and environmental factors.

Atrophy is a medical term that refers to the decrease in size and wasting of an organ or tissue due to the disappearance of cells, shrinkage of cells, or decreased number of cells. This process can be caused by various factors such as disuse, aging, degeneration, injury, or disease.

For example, if a muscle is immobilized for an extended period, it may undergo atrophy due to lack of use. Similarly, certain medical conditions like diabetes, cancer, and heart failure can lead to the wasting away of various tissues and organs in the body.

Atrophy can also occur as a result of natural aging processes, leading to decreased muscle mass and strength in older adults. In general, atrophy is characterized by a decrease in the volume or weight of an organ or tissue, which can have significant impacts on its function and overall health.

Malabsorption syndromes refer to a group of disorders in which the small intestine is unable to properly absorb nutrients from food, leading to various gastrointestinal and systemic symptoms. This can result from a variety of underlying conditions, including:

1. Mucosal damage: Conditions such as celiac disease, inflammatory bowel disease (IBD), or bacterial overgrowth that cause damage to the lining of the small intestine, impairing nutrient absorption.
2. Pancreatic insufficiency: A lack of digestive enzymes produced by the pancreas can lead to poor breakdown and absorption of fats, proteins, and carbohydrates. Examples include chronic pancreatitis or cystic fibrosis.
3. Bile acid deficiency: Insufficient bile acids, which are necessary for fat emulsification and absorption, can result in steatorrhea (fatty stools) and malabsorption. This may occur due to liver dysfunction, gallbladder removal, or ileal resection.
4. Motility disorders: Abnormalities in small intestine motility can affect nutrient absorption, as seen in conditions like gastroparesis, intestinal pseudo-obstruction, or scleroderma.
5. Structural abnormalities: Congenital or acquired structural defects of the small intestine, such as short bowel syndrome, may lead to malabsorption.
6. Infections: Certain bacterial, viral, or parasitic infections can cause transient malabsorption by damaging the intestinal mucosa or altering gut flora.

Symptoms of malabsorption syndromes may include diarrhea, steatorrhea, bloating, abdominal cramps, weight loss, and nutrient deficiencies. Diagnosis typically involves a combination of clinical evaluation, laboratory tests, radiologic imaging, and sometimes endoscopic procedures to identify the underlying cause. Treatment is focused on addressing the specific etiology and providing supportive care to manage symptoms and prevent complications.

A protein-restricted diet is a medical nutrition plan that limits the daily intake of protein. This type of diet may be recommended for individuals with certain kidney or liver disorders, as reducing protein intake can help decrease the workload on these organs and prevent further damage. The specific amount of protein restriction will depend on the individual's medical condition, overall health status, and prescribing healthcare professional's guidance.

It is essential to ensure that a protein-restricted diet is nutritionally adequate and balanced, providing sufficient calories, carbohydrates, fats, vitamins, and minerals. A registered dietitian or nutritionist should closely supervise the implementation of such a diet to prevent potential nutrient deficiencies and other related complications. In some cases, medical supplements may be necessary to meet the individual's nutritional requirements.

Individuals on a protein-restricted diet should avoid high-protein foods like meat, poultry, fish, eggs, dairy products, legumes, and nuts. Instead, they should focus on consuming low-protein or protein-free alternatives, such as fruits, vegetables, refined grains, and specific medical food products designed for individuals with special dietary needs.

It is crucial to consult a healthcare professional before starting any new diet, particularly one that restricts essential nutrients like protein. A healthcare provider can help determine if a protein-restricted diet is appropriate and ensure it is implemented safely and effectively.

Wheat hypersensitivity is a general term that refers to adverse reactions to wheat proteins. It can be divided into two main types: food allergies and non-celiac gluten or wheat sensitivity (NCGWS).

1. Food Allergy: This is an immune-mediated reaction to one or more wheat proteins, such as gliadin, glutenin, albumin, and globulin. In this case, the body's immune system mistakenly identifies these proteins as harmful and produces antibodies (IgE) against them. This can lead to symptoms like hives, swelling, itching, difficulty breathing, or anaphylaxis shortly after ingesting wheat.

2. Non-Celiac Gluten or Wheat Sensitivity: This is a non-immune mediated reaction to wheat proteins, where the body does not produce IgE antibodies. The exact mechanisms are not fully understood, but it's believed that other components of wheat, such as fermentable oligo-, di-, monosaccharides and polyols (FODMAPs) or amylase-trypsin inhibitors (ATIs), may contribute to the symptoms. These can include gastrointestinal issues like bloating, diarrhea, and stomach pain, as well as non-gastrointestinal symptoms such as fatigue, headaches, and joint pain. Unlike celiac disease, NCGWS does not cause damage to the small intestine.

Serologic tests are laboratory tests that detect the presence or absence of antibodies or antigens in a patient's serum (the clear liquid that separates from clotted blood). These tests are commonly used to diagnose infectious diseases, as well as autoimmune disorders and other medical conditions.

In serologic testing for infectious diseases, a sample of the patient's blood is collected and allowed to clot. The serum is then separated from the clot and tested for the presence of antibodies that the body has produced in response to an infection. The test may be used to identify the specific type of infection or to determine whether the infection is active or has resolved.

Serologic tests can also be used to diagnose autoimmune disorders, such as rheumatoid arthritis and lupus, by detecting the presence of antibodies that are directed against the body's own tissues. These tests can help doctors confirm a diagnosis and monitor the progression of the disease.

It is important to note that serologic tests are not always 100% accurate and may produce false positive or false negative results. Therefore, they should be interpreted in conjunction with other clinical findings and laboratory test results.

Lactulose is a synthetic disaccharide, specifically a non-absorbable sugar, used in the treatment of chronic constipation and hepatic encephalopathy. It works as an osmotic laxative by drawing water into the large intestine, promoting bowel movements and softening stool. In the case of hepatic encephalopathy, lactulose is metabolized by colonic bacteria to produce acidic byproducts that lower the pH in the gut, which helps prevent the absorption of harmful substances like ammonia into the bloodstream.

Duodenoscopy is a medical procedure that involves the insertion of a duodenoscope, which is a flexible, lighted tube with a camera and tiny tools on the end, through the mouth and down the throat to examine the upper part of the small intestine (duodenum) and the opening of the bile and pancreatic ducts.

During the procedure, the doctor can take tissue samples for biopsy, remove polyps or other abnormal growths, or perform other interventions as needed. Duodenoscopy is commonly used to diagnose and treat conditions such as gastrointestinal bleeding, inflammation, infection, and cancer.

It's important to note that duodenoscopes have been associated with the spread of antibiotic-resistant bacteria in some cases, so healthcare providers must follow strict cleaning and disinfection protocols to minimize this risk.

Gastrointestinal endoscopy is a medical procedure that allows direct visualization of the inner lining of the digestive tract, which includes the esophagus, stomach, small intestine, large intestine (colon), and sometimes the upper part of the small intestine (duodenum). This procedure is performed using an endoscope, a long, thin, flexible tube with a light and camera at its tip. The endoscope is inserted through the mouth for upper endoscopy or through the rectum for lower endoscopy (colonoscopy), and the images captured by the camera are transmitted to a monitor for the physician to view.

Gastrointestinal endoscopy can help diagnose various conditions, such as inflammation, ulcers, tumors, polyps, or bleeding in the digestive tract. It can also be used for therapeutic purposes, such as removing polyps, taking tissue samples (biopsies), treating bleeding, and performing other interventions to manage certain digestive diseases.

There are different types of gastrointestinal endoscopy procedures, including:

1. Upper Endoscopy (Esophagogastroduodenoscopy or EGD): This procedure examines the esophagus, stomach, and duodenum.
2. Colonoscopy: This procedure examines the colon and rectum.
3. Sigmoidoscopy: A limited examination of the lower part of the colon (sigmoid colon) using a shorter endoscope.
4. Enteroscopy: An examination of the small intestine, which can be performed using various techniques, such as push enteroscopy, single-balloon enteroscopy, or double-balloon enteroscopy.
5. Capsule Endoscopy: A procedure that involves swallowing a small capsule containing a camera, which captures images of the digestive tract as it passes through.

Gastrointestinal endoscopy is generally considered safe when performed by experienced medical professionals. However, like any medical procedure, there are potential risks and complications, such as bleeding, infection, perforation, or adverse reactions to sedatives used during the procedure. Patients should discuss these risks with their healthcare provider before undergoing gastrointestinal endoscopy.

Antibodies are proteins produced by the immune system in response to the presence of a foreign substance, such as a bacterium or virus. They are capable of identifying and binding to specific antigens (foreign substances) on the surface of these invaders, marking them for destruction by other immune cells. Antibodies are also known as immunoglobulins and come in several different types, including IgA, IgD, IgE, IgG, and IgM, each with a unique function in the immune response. They are composed of four polypeptide chains, two heavy chains and two light chains, that are held together by disulfide bonds. The variable regions of the heavy and light chains form the antigen-binding site, which is specific to a particular antigen.

Immunoglobulin G (IgG) is a type of antibody, which is a protective protein produced by the immune system in response to foreign substances like bacteria or viruses. IgG is the most abundant type of antibody in human blood, making up about 75-80% of all antibodies. It is found in all body fluids and plays a crucial role in fighting infections caused by bacteria, viruses, and toxins.

IgG has several important functions:

1. Neutralization: IgG can bind to the surface of bacteria or viruses, preventing them from attaching to and infecting human cells.
2. Opsonization: IgG coats the surface of pathogens, making them more recognizable and easier for immune cells like neutrophils and macrophages to phagocytose (engulf and destroy) them.
3. Complement activation: IgG can activate the complement system, a group of proteins that work together to help eliminate pathogens from the body. Activation of the complement system leads to the formation of the membrane attack complex, which creates holes in the cell membranes of bacteria, leading to their lysis (destruction).
4. Antibody-dependent cellular cytotoxicity (ADCC): IgG can bind to immune cells like natural killer (NK) cells and trigger them to release substances that cause target cells (such as virus-infected or cancerous cells) to undergo apoptosis (programmed cell death).
5. Immune complex formation: IgG can form immune complexes with antigens, which can then be removed from the body through various mechanisms, such as phagocytosis by immune cells or excretion in urine.

IgG is a critical component of adaptive immunity and provides long-lasting protection against reinfection with many pathogens. It has four subclasses (IgG1, IgG2, IgG3, and IgG4) that differ in their structure, function, and distribution in the body.

Autoimmune diseases are a group of disorders in which the immune system, which normally protects the body from foreign invaders like bacteria and viruses, mistakenly attacks the body's own cells and tissues. This results in inflammation and damage to various organs and tissues in the body.

In autoimmune diseases, the body produces autoantibodies that target its own proteins or cell receptors, leading to their destruction or malfunction. The exact cause of autoimmune diseases is not fully understood, but it is believed that a combination of genetic and environmental factors contribute to their development.

There are over 80 different types of autoimmune diseases, including rheumatoid arthritis, lupus, multiple sclerosis, type 1 diabetes, Hashimoto's thyroiditis, Graves' disease, psoriasis, and inflammatory bowel disease. Symptoms can vary widely depending on the specific autoimmune disease and the organs or tissues affected. Treatment typically involves managing symptoms and suppressing the immune system to prevent further damage.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

T-cell lymphoma is a type of cancer that affects the T-cells, which are a specific type of white blood cell responsible for immune function. These lymphomas develop from mature T-cells and can be classified into various subtypes based on their clinical and pathological features.

T-cell lymphomas can arise in many different organs, including the lymph nodes, skin, and other soft tissues. They often present with symptoms such as enlarged lymph nodes, fever, night sweats, and weight loss. The diagnosis of T-cell lymphoma typically involves a biopsy of the affected tissue, followed by immunophenotyping and genetic analysis to determine the specific subtype.

Treatment for T-cell lymphomas may include chemotherapy, radiation therapy, immunotherapy, or stem cell transplantation, depending on the stage and aggressiveness of the disease. The prognosis for T-cell lymphoma varies widely depending on the subtype and individual patient factors.

Steatorrhea is a medical condition characterized by the excessive amount of fat in stools, which can make them appear greasy, frothy, and foul-smelling. This occurs due to poor absorption of dietary fats in the intestines, a process called malabsorption. The most common causes of steatorrhea include conditions that affect the pancreas, such as cystic fibrosis or chronic pancreatitis, celiac disease, and other gastrointestinal disorders. Symptoms associated with steatorrhea may include abdominal pain, bloating, diarrhea, weight loss, and vitamin deficiencies due to malabsorption of fat-soluble vitamins (A, D, E, K). The diagnosis typically involves testing stool samples for fat content and further investigations to determine the underlying cause. Treatment is focused on addressing the underlying condition and providing dietary modifications to manage symptoms.

Duodenitis is a medical condition characterized by inflammation of the duodenum, which is the first part of the small intestine that receives chyme (partially digested food) from the stomach. The inflammation can cause symptoms such as abdominal pain, nausea, vomiting, and loss of appetite.

Duodenitis can be caused by various factors, including bacterial infections (such as Helicobacter pylori), regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), excessive alcohol consumption, and autoimmune disorders like Crohn's disease. In some cases, the cause may remain unidentified, leading to a diagnosis of "non-specific duodenitis."

Treatment for duodenitis typically involves addressing the underlying cause, such as eradicating H. pylori infection or discontinuing NSAID use. Acid-suppressing medications and antacids may also be prescribed to alleviate symptoms and promote healing of the duodenal lining. In severe cases, endoscopic procedures or surgery might be necessary to manage complications like bleeding, perforation, or obstruction.

Capsule endoscopy is a medical procedure that uses a small, pill-sized camera to capture images of the digestive tract. The capsule is swallowed and transmits images wirelessly as it moves through the gastrointestinal (GI) tract, allowing doctors to examine the lining of the small intestine, which can be difficult to reach with traditional endoscopes.

The procedure is commonly used to diagnose and monitor conditions such as Crohn's disease, celiac disease, obscure gastrointestinal bleeding, and tumors in the small intestine. The images captured by the capsule are transmitted to a recorder worn by the patient, and then reviewed and analyzed by a healthcare professional.

Capsule endoscopy is generally considered safe and non-invasive, with few risks or side effects. However, it may not be suitable for everyone, including patients with swallowing difficulties, pacemakers, or certain gastrointestinal obstructions. It's important to consult with a healthcare provider to determine if capsule endoscopy is the right diagnostic tool for a particular condition.

Jejunal neoplasms refer to abnormal growths or tumors in the jejunum, which is the middle section of the small intestine. These neoplasms can be benign (non-cancerous) or malignant (cancerous). Malignant jejunal neoplasms are often aggressive and can spread to other parts of the body, making them potentially life-threatening.

There are several types of jejunal neoplasms, including:

1. Adenocarcinomas: These are cancerous tumors that develop from the glandular cells lining the jejunum. They are the most common type of jejunal neoplasm.
2. Carcinoid tumors: These are slow-growing neuroendocrine tumors that arise from the hormone-producing cells in the jejunum. While they are usually benign, some can become malignant and spread to other parts of the body.
3. Gastrointestinal stromal tumors (GISTs): These are rare tumors that develop from the connective tissue cells in the jejunum. They can be benign or malignant.
4. Lymphomas: These are cancerous tumors that develop from the immune system cells in the jejunum. They are less common than adenocarcinomas but can be aggressive and spread to other parts of the body.
5. Sarcomas: These are rare cancerous tumors that develop from the connective tissue cells in the jejunum. They can be aggressive and spread to other parts of the body.

Symptoms of jejunal neoplasms may include abdominal pain, bloating, diarrhea, weight loss, and bleeding in the stool. Treatment options depend on the type and stage of the neoplasm but may include surgery, chemotherapy, radiation therapy, or a combination of these approaches.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Jejunal diseases refer to a range of medical conditions that affect the jejunum, which is the middle section of the small intestine. These diseases can cause various symptoms such as abdominal pain, diarrhea, bloating, nausea, vomiting, and weight loss. Some examples of jejunal diseases include:

1. Jejunal inflammation or infection (jejunitis)
2. Crohn's disease, which can affect any part of the gastrointestinal tract including the jejunum
3. Intestinal lymphoma, a type of cancer that can develop in the small intestine
4. Celiac disease, an autoimmune disorder that causes damage to the small intestine when gluten is consumed
5. Intestinal bacterial overgrowth (SIBO), which can occur due to various reasons including structural abnormalities or motility disorders of the jejunum
6. Meckel's diverticulum, a congenital condition where a small pouch protrudes from the wall of the intestine, usually located in the ileum but can also affect the jejunum
7. Intestinal strictures or obstructions caused by scarring, adhesions, or tumors
8. Radiation enteritis, damage to the small intestine caused by radiation therapy for cancer treatment.

The diagnosis and management of jejunal diseases depend on the specific condition and its severity. Treatment options may include medications, dietary modifications, surgery, or a combination of these approaches.

Intestinal neoplasms refer to abnormal growths in the tissues of the intestines, which can be benign or malignant. These growths are called neoplasms and they result from uncontrolled cell division. In the case of intestinal neoplasms, these growths occur in the small intestine, large intestine (colon), rectum, or appendix.

Benign intestinal neoplasms are not cancerous and often do not invade surrounding tissues or spread to other parts of the body. However, they can still cause problems if they grow large enough to obstruct the intestines or cause bleeding. Common types of benign intestinal neoplasms include polyps, leiomyomas, and lipomas.

Malignant intestinal neoplasms, on the other hand, are cancerous and can invade surrounding tissues and spread to other parts of the body. The most common type of malignant intestinal neoplasm is adenocarcinoma, which arises from the glandular cells lining the inside of the intestines. Other types of malignant intestinal neoplasms include lymphomas, sarcomas, and carcinoid tumors.

Symptoms of intestinal neoplasms can vary depending on their size, location, and type. Common symptoms include abdominal pain, bloating, changes in bowel habits, rectal bleeding, weight loss, and fatigue. If you experience any of these symptoms, it is important to seek medical attention promptly.

Enteropathy-associated T-cell lymphoma (EATL) is a rare type of lymphoma that is associated with celiac disease, an autoimmune disorder of the small intestine triggered by gluten ingestion. EATL is a form of intestinal T-cell lymphoma and typically affects older adults, with a median age at diagnosis in the sixth to seventh decade of life.

EATL is characterized by the malignant transformation of T-cells, a type of white blood cell, that are present in the intestinal wall. The exact cause of EATL is not fully understood, but it is strongly associated with celiac disease and its complications, such as chronic inflammation and malabsorption.

Symptoms of EATL may include abdominal pain, diarrhea, weight loss, nausea, vomiting, and intestinal obstruction or perforation. The diagnosis of EATL is typically made through a combination of clinical evaluation, imaging studies, endoscopy with biopsy, and laboratory tests.

Treatment for EATL usually involves a combination of chemotherapy, radiation therapy, and surgery to remove the affected portion of the intestine. The prognosis for patients with EATL is generally poor, with a five-year survival rate of less than 20%. However, early diagnosis and aggressive treatment may improve outcomes in some cases.

Enteritis is a medical term that refers to inflammation of the small intestine. The small intestine is responsible for digesting and absorbing nutrients from food, so inflammation in this area can interfere with these processes and lead to symptoms such as diarrhea, abdominal pain, nausea, vomiting, and weight loss.

Enteritis can be caused by a variety of factors, including bacterial or viral infections, parasites, autoimmune disorders, medications, and exposure to toxins. In some cases, the cause of enteritis may be unknown. Treatment for enteritis depends on the underlying cause, but may include antibiotics, antiparasitic drugs, anti-inflammatory medications, or supportive care such as fluid replacement therapy.

An Enzyme-Linked Immunosorbent Assay (ELISA) is a type of analytical biochemistry assay used to detect and quantify the presence of a substance, typically a protein or peptide, in a liquid sample. It takes its name from the enzyme-linked antibodies used in the assay.

In an ELISA, the sample is added to a well containing a surface that has been treated to capture the target substance. If the target substance is present in the sample, it will bind to the surface. Next, an enzyme-linked antibody specific to the target substance is added. This antibody will bind to the captured target substance if it is present. After washing away any unbound material, a substrate for the enzyme is added. If the enzyme is present due to its linkage to the antibody, it will catalyze a reaction that produces a detectable signal, such as a color change or fluorescence. The intensity of this signal is proportional to the amount of target substance present in the sample, allowing for quantification.

ELISAs are widely used in research and clinical settings to detect and measure various substances, including hormones, viruses, and bacteria. They offer high sensitivity, specificity, and reproducibility, making them a reliable choice for many applications.

Enterocytes are the absorptive cells that line the villi of the small intestine. They are a type of epithelial cell and play a crucial role in the absorption of nutrients from food into the bloodstream. Enterocytes have finger-like projections called microvilli on their apical surface, which increases their surface area and enhances their ability to absorb nutrients. They also contain enzymes that help digest and break down carbohydrates, proteins, and fats into smaller molecules that can be absorbed. Additionally, enterocytes play a role in the absorption of ions, water, and vitamins.

Intestinal diseases refer to a wide range of conditions that affect the function or structure of the small intestine, large intestine (colon), or both. These diseases can cause various symptoms such as abdominal pain, diarrhea, constipation, bloating, nausea, vomiting, and weight loss. They can be caused by infections, inflammation, genetic disorders, or other factors. Some examples of intestinal diseases include inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, Crohn's disease, ulcerative colitis, and intestinal infections. The specific medical definition may vary depending on the context and the specific condition being referred to.

Microscopic colitis is a type of inflammatory bowel disease that is characterized by chronic inflammation of the colon (large intestine) that can only be seen under a microscope. It is called "microscopic" because the inflammation is not visible to the naked eye during endoscopic examination of the colon.

There are two main types of microscopic colitis: collagenous colitis and lymphocytic colitis. Both types are more common in older adults, particularly women, and can cause chronic watery diarrhea that may be accompanied by abdominal cramps, bloating, and nausea.

In collagenous colitis, there is thickening of the collagen band (a layer of tissue) beneath the lining of the colon. In lymphocytic colitis, there is an increase in the number of lymphocytes (a type of white blood cell) in the lining of the colon.

The exact cause of microscopic colitis is not known, but it is thought to be related to a combination of genetic, environmental, and immune factors. Treatment typically involves medications to reduce inflammation and manage symptoms, such as anti-diarrheal agents, corticosteroids, and immunosuppressive drugs. In some cases, dietary modifications or elimination of certain foods may also help alleviate symptoms.

Endoscopy of the digestive system, also known as gastrointestinal (GI) endoscopy, is a medical procedure that allows healthcare professionals to visually examine the inside lining of the digestive tract using a flexible tube with a light and camera attached to it, called an endoscope. This procedure can help diagnose and treat various conditions affecting the digestive system, including gastroesophageal reflux disease (GERD), ulcers, inflammatory bowel disease (IBD), and cancer.

There are several types of endoscopy procedures that focus on different parts of the digestive tract:

1. Esophagogastroduodenoscopy (EGD): This procedure examines the esophagus, stomach, and duodenum (the first part of the small intestine). It is often used to investigate symptoms such as difficulty swallowing, abdominal pain, or bleeding in the upper GI tract.
2. Colonoscopy: This procedure explores the large intestine (colon) and rectum. It is commonly performed to screen for colon cancer, as well as to diagnose and treat conditions like inflammatory bowel disease, diverticulosis, or polyps.
3. Sigmoidoscopy: Similar to a colonoscopy, this procedure examines the lower part of the colon (sigmoid colon) and rectum. It is often used as a screening tool for colon cancer and to investigate symptoms like rectal bleeding or changes in bowel habits.
4. Upper GI endoscopy: This procedure focuses on the esophagus, stomach, and duodenum, using a thin, flexible tube with a light and camera attached to it. It is used to diagnose and treat conditions such as GERD, ulcers, and difficulty swallowing.
5. Capsule endoscopy: This procedure involves swallowing a small capsule containing a camera that captures images of the digestive tract as it passes through. It can help diagnose conditions in the small intestine that may be difficult to reach with traditional endoscopes.

Endoscopy is typically performed under sedation or anesthesia to ensure patient comfort during the procedure. The images captured by the endoscope are displayed on a monitor, allowing the healthcare provider to assess the condition of the digestive tract and make informed treatment decisions.

In those with celiac disease before diagnosis (on a gluten-containing diet), celiac disease serological markers are not always ... The main goal in diagnosing NCGS is to exclude celiac disease. NCGS and celiac disease cannot be separated in diagnosis because ... and there are people with celiac disease having negative serology (absence of specific celiac disease antibodies in serum) or ... might be specific markers for celiac disease. Catassi and Fasano proposed in 2010 that in patients without celiac disease ...
Benson had celiac disease and attributed his adoption of a gluten-free diet to giving him more energy. After his NFL career, ... In October 2009, Benson confirmed that shortly before he was released by the Bears, he had been diagnosed with Celiac disease. ... "Thanks Lovie, From Cedric and Tank". Celiac Disease. October 25, 2009. Retrieved June 3, 2021. Bien, Louis (March 9, 2016). " ... Longhorns football All-Americans List of Chicago Bears first-round draft picks List of people diagnosed with coeliac disease ...
"Celiac Disease". NIDDKD. June 2015. Archived from the original on 13 March 2016. Retrieved 17 March 2016. "Celiac disease". ... Celiac disease. While it is caused by a permanent intolerance to gluten (present in wheat, rye, barley and oats), is not an ... Tommasini A, Not T, Ventura A (August 2011). "Ages of celiac disease: from changing environment to improved diagnostics". World ... To a lesser frequency, people may be mildly allergic to raw fruits and vegetables, a disease known as oral allergy syndrome. ...
"Celiac Disease". Archived from the original on 2009-07-20. Meize-Grochowski R (2005). "Celiac disease: a multisystem autoimmune ... Sollid LM, Jabri B (December 2005). "Is celiac disease an autoimmune disorder?". Current Opinion in Immunology. 17 (6): 595-600 ... This list of autoimmune diseases is categorized by organ and tissue type to help locate diseases that may be similar. Overview ... These conditions are included here because: The disease was listed in the prior version of this table The disease is included ...
"Definition and Facts for Celiac Disease". The National Institute of Diabetes and Digestive and Kidney Diseases, National ... While coeliac disease is caused by a reaction to wheat proteins, it is not the same as a wheat allergy. Other diseases ... Both of these diseases are soil borne. Stem rust diseases: Caused by Puccinia graminis f. sp. tritici (basidiomycete) fungi e.g ... "Celiac disease". World Gastroenterology Organisation Global Guidelines. July 2016. Retrieved 7 December 2016. " ...
Rostami Nejad M, Hogg-Kollars S, Ishaq S, Rostami K (2011). "Subclinical celiac disease and gluten sensitivity". ... National Research Council (2003). "Johne's Disease and Crohn's Disease". Diagnosis and Control of Johne's Disease. Washington, ... Grave's disease and Crohn's disease. Coghlan A (January 10, 2018). "A single gene can either raise or lower Crohn's disease ... Crohn's disease is a type of inflammatory bowel disease (IBD) that may affect any segment of the gastrointestinal tract. ...
"Definition and Facts for Celiac Disease". The National Institute of Diabetes and Digestive and Kidney Diseases, National ... coeliac disease. "Celiac disease". World Gastroenterology Organisation Global Guidelines. July 2016. Retrieved 7 December 2016 ... While coeliac disease is caused by a reaction to wheat proteins, it is not the same as a wheat allergy. Other diseases ... can trigger coeliac disease. Coeliac disease affects about 1% of the general population in developed countries. There is ...
Lebwohl B, Ludvigsson JF, Green PH (October 2015). "Celiac disease and non-celiac gluten sensitivity". BMJ (Review). 351: h4347 ... Other conditions that may present similarly include celiac disease, microscopic colitis, inflammatory bowel disease, bile acid ... celiac disease, or inflammatory bowel disease. The criteria for selecting tests and investigations also depends on the level of ... to exclude peptic ulcer disease, coeliac disease, inflammatory bowel disease, and malignancies) Hydrogen breath testing (to ...
She researches inflammatory diseases of the intestine, including celiac disease. She is an elected fellow of the Association of ... "Celiac Disease". The University of Chicago Medical Center Digestive Diseases Research Core Center. Archived from the original ... director of its Digestive Disease Research Core Center and in 2011 she was made the director of research for its Celiac Disease ... Prize for Excellence in Celiac Disease Research. In 2017 she received the Lloyd Mayer Prize in Mucosal Immunology. She is also ...
"Celiac disease". World Gastroenterology Organisation Global Guidelines. July 2016. Archived from the original on 17 March 2017 ... These symptoms, however, are also common in the presentation of coeliac disease, inflammatory bowel disease, defecatory ... indicating the presence of an unrecognized celiac disease, avoiding its diagnosis and correct treatment, with the consequent ... Misdiagnosis of intestinal diseases can lead to secondary problems such as nutritional deficiencies, cancer risk, or even ...
"Celiac disease - Symptoms and causes". Mayo Clinic. Retrieved 2020-08-02. "Celiac Disease , NIDDK". National Institute of ... Family history Conditions such as inflammatory bowel disease, cystic fibrosis, and celiac disease Physical examination involves ... Celiac Disease, a disorder in which there is an immune response to eating gluten which can eventually cause damage to the small ... "Celiac Disease". 2016. Retrieved 2020-07-31. "Gastroenteritis-Gastrointestinal Disorders". 2020. Retrieved 2020-07-20. "How to ...
Pietzak MM (2014). "Dietary supplements in celiac disease". In Rampertab SD, Mullin GE (eds.). Celiac disease. Springer. pp. ... Rewers M (April 2005). "Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease ... Coeliac disease (British English) or celiac disease (American English) is a long-term autoimmune disorder, primarily affecting ... "Symptoms & Causes of Celiac Disease , NIDDK". National Institute of Diabetes and Digestive and Kidney Diseases. June 2016. ...
Underlying associated diseases include hypothyroidism, diabetes, Parkinson's disease, celiac disease, non-celiac gluten ... Celiac disease and non-celiac gluten sensitivity may also present with constipation. Cystocele can develop as a result of ... Systemic diseases that may present with constipation include celiac disease and systemic sclerosis. Constipation has a number ... "Symptoms & Causes of Celiac Disease , NIDDK". National Institute of Diabetes and Digestive and Kidney Diseases. June 2016. ...
tTG is best known for its link with celiac disease. It was first associated with celiac disease in 1997 when the enzyme was ... tTG is the autoantigen in celiac disease, a lifelong illness in which the consumption of dietary gluten causes a pathological ... Murray JA, Frey MR, Oliva-Hemker M (June 2018). "Celiac Disease". Gastroenterology. 154 (8): 2005-2008. doi:10.1053/j.gastro. ... Klöck C, Diraimondo TR, Khosla C (July 2012). "Role of transglutaminase 2 in celiac disease pathogenesis". Seminars in ...
Cannabis withdrawal Celiac disease Chronic kidney disease Chronic pain Common cold Constipation COPD COVID-19 Crohn's disease ... Taylor AK, Lebwohl B, Snyder CL, Green PHR (17 September 2015). "Celiac Disease". GeneReviews®. PMID 20301720. Retrieved 24 ... As in humans, loss of appetite can be due to a range of diseases and conditions, as well as environmental and psychological ... Acute radiation syndrome Addison's disease Alcoholism Alcohol withdrawal Anemia Anorexia nervosa Anxiety Appendicitis ...
... is by definition related to celiac disease. Individuals are genetically predisposed to develop celiac disease because of the ... "Diagnosis and Treatment Patterns in Celiac Disease". Digestive Diseases and Sciences. 64 (8): 2095-2106. doi:10.1007/s10620-019 ... Studies show that: Celiac disease affects ~1% of the population in most parts of the world. Ninety to one hundred percent of ... Al-Bawardy B, Codipilly DC, Rubio-Tapia A, Bruining DH, Hansel SL, Murray JA (February 2017). "Celiac disease: a clinical ...
Celiac disease; is an autoimmune disorder in which the body is unable to digest gluten which is found in various food grains, ... Is It Depression--or a Tumor? - Newsweek Nov 21, 2007 Bushara KO (April 2005). "Neurologic presentation of celiac disease". ... Graves' disease: an autoimmune disease where the thyroid is overactive, resulting in hyperthyroidism and thyrotoxicosis. ... Lyme disease is one of a group of diseases which have earned the name the "great imitator" for their propensity to mimic the ...
Undiagnosed and untreated celiac disease often causes dental enamel defects and can be the only manifestation of the disease, ... It may be caused by nutritional factors, some diseases (such as undiagnosed and untreated celiac disease, chicken pox, ... Giuca MR, Cei G, Gigli F, Gandini P (2010). "Oral signs in the diagnosis of celiac disease: review of the literature". Minerva ... Rivera E, Assiri A, Guandalini S (Oct 2013). "Celiac disease". Oral Dis (Review). 19 (7): 635-41. doi:10.1111/odi.12091. PMID ...
There is a slight male predominance in DH for unknown reasons and it is associated with celiac disease and the haplotypes HLA- ... Inflammation in the gut is similar to, and linked to, celiac disease. tTG is treated as an autoantigen, especially in people ... As with ordinary celiac disease, IgA against transglutaminase disappears (often within months) when patients eliminate gluten ... Additionally, the concomitant diagnosis of Celiac disease can be made without the need for a small-intenstinal biopsy if an ...
Celiac disease is a condition that prevents the small intestine from absorbing parts of food that are needed to stay healthy. ... "Celiac disease - sprue". A.D.A.M. Medical Encyclopedia. PubMed Health. January 20, 2010. Retrieved 13 February 2012. "Colitis ... Some examples of diseases that may be associated with this symptom include carcinoid neoplasm and coeliac sprue. Louder rumbles ... Consuming food containing gluten is dangerous for people with this disease: Intestinal villi help to absorb nutrients from food ...
"What Is Celiac's Disease". Celiac Disease Foundation. "True Blood Star's Beau Is Blinded By Disease". Contactmusic.com. August ... List of people diagnosed with celiac disease "HBO: True Blood's Deborah Ann Woll Bio". HBO. Retrieved August 5, 2011. ""True ... battle with celiac disease. She is an enthusiastic Dungeons & Dragons player and has been interviewed by D&D Beyond and Dragon ... and Woll uses her platform to help raise awareness of the disease. She has said that Scott's attitude towards his disability ...
"Donate To Help Ukrainian Celiac Disease Refugees". Celiac Disease Foundation. "Tile Industry Launches Fund to Provide ...
"Jones Dairy Farm". celiac.org. Celiac Disease Foundation. Retrieved 11 April 2016. "For people with celiac disease, breakfast ... Jones also promotes awareness of celiac disease by sponsoring the Celiac Disease Foundation and is a benefactor member of the ... Celiac Sprue Association. In 2015, Jones sponsored an annual scholarship for culinary students at Pennsylvania College of ...
Celiac Disease Foundation. "Celiac Disease Foundation". "Does soy sauce contain gluten?". Soya.be. Retrieved 16 July 2010. ... less salt than regular soy sauce for consumers concerned about heart disease. Usujio (薄塩, 'light salt'): This version contains ...
Palicki has celiac disease. In September 2014, her representative confirmed that she was engaged to stuntman Jackson Spidell, ...
"Celiac Disease - MeSH - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2016-07-09. "HIV Enteropathy - MeSH - NCBI". www.ncbi.nlm.nih. ... "Eosinophilic enteropathy , Disease , Overview , Genetic and Rare Diseases Information Center (GARD) - an NCATS Program". ... Coeliac disease A malabsorption syndrome precipitated by the ingestion of foods containing gluten in a predisposed individual. ... porcine proliferative enteropathy is a diarrheal disease. "enteropathy" at Dorland's Medical Dictionary Crane, Rosie J.; Jones ...
Lyme disease Sjögren's disease Hashimoto's thyroiditis Celiac disease Non-celiac gluten sensitivity Inflammatory bowel disease ... Guandalini S, Assiri A (March 2014). "Celiac disease: a review". JAMA Pediatrics. 168 (3): 272-278. doi:10.1001/jamapediatrics. ... Arthritis is predominantly a disease of the elderly, but children can also be affected by the disease. Arthritis is more common ... "Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying ...
"A Brief History of Celiac Disease" (PDF). Impact: The University of Chicago Celiac Disease Center, Summer 2007. Summer 2007. ... "Historical Perspective of Celiac Disease". In Fasano, Alessio; Troncone, Riccardo; Branski, David (eds.). Frontiers in celiac ... Merrill P. Haas, in publishing the medical textbook The Management of Celiac Disease. "Dr. Sidney Valentine Haas Dies; ... Haas, Sidney Valentine; Haas, Merrill P. (2011). The Management of Celiac Disease. Literary Licensing. ISBN 978-1-258-19621-9. ...
Hasselbeck stated she is living with celiac disease. She has written a book on the subject, The G-Free Diet: A Gluten-Free ... Living with Celiac Disease. Bloomington, IN: Xlibris. ISBN 978-1-4415-2116-3. "Judge tosses plagiarism suit vs. 'View' star ... List of people diagnosed with celiac disease Lawrence, Brett (March 27, 2019). "Former The View Co-Host Elisabeth Hasselbeck ...
Lewis has celiac disease. "T.Lewis". World Athletics. Retrieved 16 August 2023. Burr, Brendan (7 January 2022). "Burnie New ... Gates, Zachary (15 August 2023). "EXCLUSIVE: Disease linking Aussie sprinting young gun with unlikely mentor on cusp of world ...

No FAQ available that match "celiac disease"

No images available that match "celiac disease"